资讯

Ultragenyx Pharmaceutical Inc. ( NASDAQ: RARE) Cantor Global Healthcare Conference 2025 September 4, 2025 10:55 AM EDT ...
Primary and secondary outcome measures The primary outcome was tracheal injury score, assessed via fibreoptic bronchoscopy for hyperaemia, ischaemia, ulcers and perforation. Lesions were classified as ...
Treace Medical Concepts, Inc. ( NASDAQ: TMCI) Investor Day Call September 3, 2025 9:00 AM EDT ...